immunotherapy

Limitations to the Therapeutic Potential of Tyrosine Kinase Inhibitors and Alternative Therapies for Kidney Cancer
Hossam Kamli, Li Li and Glenda C. Gobe

Ochsner Journal June 2019, 19 (2) 138-151; DOI: https://doi.org/10.31486/toj.18.0015
Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018
Tanvir F. Kabir, Aman Chauhan, Lowell Anthony and Gerhard C. Hildebrandt

Ochsner Journal December 2018, 18 (4) 370-376; DOI: https://doi.org/10.31486/toj.18.0055
Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy
Katharine Hall Thomas and Robert A. Ramirez

Ochsner Journal December 2017, 17 (4) 362-378;
The Role of Checkpoint Inhibition in Non–Small Cell Lung Cancer
Jonathan Lu and Robert A. Ramirez

Ochsner Journal December 2017, 17 (4) 379-387;
Combination Immunotherapy for High-Risk Resected and Metastatic Melanoma Patients
Adam I. Riker, Gabriela R. Rossi, Prerna Masih, L. C. Alsfeld, Fiona Denham, Lucinda Tennant, W. Jay Ramsey, Nicholas N. Vahanian and Charles J. Link

Ochsner Journal June 2014, 14 (2) 164-174;
Malignant Melanoma of the Head and Neck: A Brief Review of Pathophysiology, Current Staging, and Management
Christian Hasney, R. Brent Butcher and Ronald G. Amedee

Ochsner Journal December 2008, 8 (4) 181-185;

Main menu